These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 14409328)

  • 1. The glyoxalase I activity of arterial tissue in individuals of various ages.
    KIRK JE
    J Gerontol; 1960 Apr; 15():139-41. PubMed ID: 14409328
    [No Abstract]   [Full Text] [Related]  

  • 2. The enolase activity of arterial tissue in individuals of various ages.
    WANG I; KIRK JE
    J Gerontol; 1959 Oct; 14():444-6. PubMed ID: 13842794
    [No Abstract]   [Full Text] [Related]  

  • 3. The aconitase activity of arterial tissue in individuals of various ages.
    KIRK JE
    J Gerontol; 1961 Jan; 16():25-8. PubMed ID: 13756237
    [No Abstract]   [Full Text] [Related]  

  • 4. Mechanism of the action of glyoxalase I.
    ROSE IA
    Biochim Biophys Acta; 1957 Jul; 25(1):214-5. PubMed ID: 13445752
    [No Abstract]   [Full Text] [Related]  

  • 5. Glyoxalase; the role of the components.
    CROOK EM; LAW K
    Biochem J; 1952 Nov; 52(3):492-9. PubMed ID: 13018264
    [No Abstract]   [Full Text] [Related]  

  • 6. Glyoxalase and methylglyoxal in thiamine-deficient rats.
    SALEM HM
    Biochem J; 1954 Jun; 57(2):227-30. PubMed ID: 13172173
    [No Abstract]   [Full Text] [Related]  

  • 7. The mechanism of the glyoxalase I reaction, and the effect of ophthalmic acid as an inhibitor.
    CLIFFE EE; WALEY SG
    Biochem J; 1961 Jun; 79(3):475-82. PubMed ID: 13694091
    [No Abstract]   [Full Text] [Related]  

  • 8. Advanced Glycation Endproducts Are Increased in the Animal Model of Multiple Sclerosis but Cannot Be Reduced by Pyridoxamine Treatment or Glyoxalase 1 Overexpression.
    Wetzels S; Wouters K; Miyata T; Scheijen JLJM; Hendriks JJA; Schalkwijk CG; Vanmierlo T
    Int J Mol Sci; 2018 Apr; 19(5):. PubMed ID: 29702605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Knowledge on glyoxalases].
    WIELAND T; PFLEIDERER G; LAU HH
    Biochem Z; 1956; 327(6):393-406. PubMed ID: 13341917
    [No Abstract]   [Full Text] [Related]  

  • 10. The accumulation of advanced glycation end-products in a schizophrenic patient with a glyoxalase 1 frameshift mutation: An autopsy study.
    Torii Y; Iritani S; Sekiguchi H; Habuchi C; Fujishiro H; Kushima I; Kawakami I; Itokawa M; Arai M; Hayashida S; Masaki K; Kira JI; Kawashima K; Ozaki N
    Schizophr Res; 2020 Sep; 223():356-358. PubMed ID: 33008688
    [No Abstract]   [Full Text] [Related]  

  • 11. Dicarbonyls and glyoxalase in disease mechanisms and clinical therapeutics.
    Rabbani N; Xue M; Thornalley PJ
    Glycoconj J; 2016 Aug; 33(4):513-25. PubMed ID: 27406712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mediterranean Diet Supplemented With Coenzyme Q10 Modulates the Postprandial Metabolism of Advanced Glycation End Products in Elderly Men and Women.
    Lopez-Moreno J; Quintana-Navarro GM; Delgado-Lista J; Garcia-Rios A; Alcala-Diaz JF; Gomez-Delgado F; Camargo A; Perez-Martinez P; Tinahones FJ; Striker GE; Perez-Jimenez F; Villalba JM; Lopez-Miranda J; Yubero-Serrano EM
    J Gerontol A Biol Sci Med Sci; 2018 Mar; 73(3):340-346. PubMed ID: 28329789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular mechanisms and consequences of glycation in atherosclerosis and obesity.
    López-Díez R; Shekhtman A; Ramasamy R; Schmidt AM
    Biochim Biophys Acta; 2016 Dec; 1862(12):2244-2252. PubMed ID: 27166197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Glyoxalase-I (Glo-I), Advanced Glycation Endproducts (AGEs), and Their Receptor (RAGE) in Chronic Liver Disease and Hepatocellular Carcinoma (HCC).
    Hollenbach M
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29156655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced glycation end products in the pathogenesis of chronic kidney disease.
    Rabbani N; Thornalley PJ
    Kidney Int; 2018 Apr; 93(4):803-813. PubMed ID: 29477239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ribose-5-phosphate isomerase activity of arterial tissue in individuals of various ages.
    KIRK JE
    J Gerontol; 1959 Oct; 14():447-9. PubMed ID: 14409331
    [No Abstract]   [Full Text] [Related]  

  • 17. Glyoxalase I deficiency is associated with an unusual level of advanced glycation end products in a hemodialysis patient.
    Miyata T; van Ypersele de Strihou C; Imasawa T; Yoshino A; Ueda Y; Ogura H; Kominami K; Onogi H; Inagi R; Nangaku M; Kurokawa K
    Kidney Int; 2001 Dec; 60(6):2351-9. PubMed ID: 11737610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The glycogen phosphorylase activity of arterial tissue in individuals of various ages.
    KIRK JE
    J Gerontol; 1962 Apr; 17():154-7. PubMed ID: 14456297
    [No Abstract]   [Full Text] [Related]  

  • 19. Polymorphisms of the receptor for advanced glycation end products and glyoxalase I and long-term outcome in patients with breast cancer.
    Tesarova P; Zima T; Kubena AA; Kalousova M
    Tumour Biol; 2017 Jul; 39(7):1010428317702902. PubMed ID: 28695773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The purine nucleoside phosphorylase activity of arterial tissue in individuals of various ages.
    KIRK JE
    J Gerontol; 1961 Jul; 16():243-6. PubMed ID: 13756238
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.